Sean Laaman
Stock Analyst at Morgan Stanley
(4.8)
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
IRON Disc Medicine | Maintains: Overweight | 85 90 | 60.86 | 47.88% | 2 | Aug 18, 2025 | |
EXEL Exelixis | Maintains: Overweight | 48 46 | 38.17 | 20.51% | 1 | Jul 29, 2025 | |
AXSM Axsome Therapeutics | Assumes: Overweight | 190 | 123.94 | 53.3% | 1 | Jul 3, 2025 | |
CERT Certara | Assumes: Equal-Weight | 16 | 10.61 | 50.8% | 1 | Jul 3, 2025 | |
ONC BeOne Medicines | Maintains: Overweight | 313 330 | 331.62 | -0.49% | 1 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Underweight | 3 2 | 2.92 | -48.63% | 1 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 300 | 184.71 | 62.42% | 1 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 169 | 274.35 | -38.4% | 1 | Oct 27, 2023 |